news Uncovering the changes to β-cells at the onset of type 1 diabetes 27 February 2024 | By Drug Target Review A new study provides more clarity about the immune events surrounding the onset of T1D, including a new mechanism that could be used for β-cell protection.
news Technique developed for delivery of iPSCs to treat type I diabetes mellitus 6 April 2021 | By Victoria Rees (Drug Target Review) A team has developed a lotus-root-shaped construct to deliver iPSC-derived pancreatic beta-cells to patients with type I diabetes mellitus.